经导管主动脉瓣置换 - The Left Main and Coronary Artery Bifurcation Lesion Summit (CBS)

Abstract

Transcatheter aortic-valve replacement with a self-expanding prosthesis
Late kidney injury after transcatheter aortic valve replacement
Frailty and Bleeding in Older Adults Undergoing TAVR or SAVR: Insights From the FRAILTY-AVR Study
Left Ventricular Rapid Pacing Via the Valve Delivery Guidewire in Transcatheter Aortic Valve Implantation
Precision Medicine in TAVR: How to Select the Right Device for the Right Patient
Prevalence and Outcomes of Concomitant Aortic Stenosis and Cardiac Amyloidosis
Contemporary real-world outcomes of surgical aortic valve replacement in 141,905 low-risk, intermediate-risk, and high-risk patients
Temporal Trends in Transcatheter Aortic Valve Replacement in France: FRANCE 2 to FRANCE TAVI
Aspirin with or without Clopidogrel after Transcatheter Aortic-Valve Implantation
Safety and efficacy of a self-expanding versus a balloon-expandable bioprosthesis for transcatheter aortic valve replacement in patients with symptomatic severe aortic stenosis: a randomised non-inferiority trial

Clinical Trial

2015 May 26;65(20):2184-94.

JOURNAL：J Am Coll Cardiol.

Transcatheter Versus Surgical Aortic Valve Replacement in Patients With Severe Aortic Valve Stenosis: 1-Year Results From the All-Comers NOTION Randomized Clinical Trial

Thyregod HG, Steinbrüchel DA, Ihlemann N et al.

6602

Keywords: severe aortic valve stenosis; low-risk patients; self-expanding bioprosthesis; TAVI; SAVR; 1-year outcome

FULL TEXT PDF